Kumar, S., & Goldschmidt, H. (2012). Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study. Leukemia, 26(1), . https://doi.org/10.1038/leu.2011.196
Chicago-Zitierstil (17. Ausg.)Kumar, Shaji, und Hartmut Goldschmidt. "Risk of Progression and Survival in Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study." Leukemia 26, no. 1 (2012). https://doi.org/10.1038/leu.2011.196.
MLA-Zitierstil (9. Ausg.)Kumar, Shaji, und Hartmut Goldschmidt. "Risk of Progression and Survival in Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study." Leukemia, vol. 26, no. 1, 2012, https://doi.org/10.1038/leu.2011.196.